A Carrier for Non-Covalent Delivery of Functional Beta-Galactosidase and Antibodies against Amyloid Plaques and IgM to the Brain

BACKGROUND: Therapeutic intervention of numerous brain-associated disorders currently remains unrealized due to serious limitations imposed by the blood-brain-barrier (BBB). The BBB generally allows transport of small molecules, typically <600 daltons with high octanol/water partition coefficient...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarkar, Gobinda, Curran, Geoffry L., Mahlum, Eric, Decklever, Teresa, Wengenack, Thomas M., Blahnik, Anthony, Hoesley, Bridget, Lowe, Val J., Poduslo, Joseph F., Jenkins, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244419/
https://www.ncbi.nlm.nih.gov/pubmed/22216132
http://dx.doi.org/10.1371/journal.pone.0028881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3244419/
https://www.ncbi.nlm.nih.gov/pubmed/22216132
http://dx.doi.org/10.1371/journal.pone.0028881

Ejemplares similares